• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Tracey Technologies Upgrades iTrace Software

    Foster Corporation Rebrands its Distribution Business

    Greenleaf Health Recruits Two Former FDA Officials

    TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada

    FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    The Changing Face of Medtech Surface Treatment

    The Totally Tubular Technologies that Support Medical Devices

    Simply Stimulating: Examining the Neurostimulation Sector

    Sensing Technology Drives the Future of Medical Care

    New and Developing Diabetes Technologies Offer 'Sweet Relief'
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Timeline Mystery for Updated EtO Rules

    An Update on Hospital Trends Post-Pandemic

    Don’t Fear the Audit: Benefits of Good Quality Practices

    Understanding the FDA’s Standards & Conformity Assessment Program

    Medtech Divestitures Are Good for Medtech Innovation
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Providence Enterprise USA Inc.

    NDH Medical Inc.

    Cirtec Medical

    Forefront Medical Technology

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Designing for Manufacturing: 5 Common Startup Mistakes (and How to Avoid Them)

    5 Challenges Medtech Must Address to Transform Healthcare

    3D Printing Medical Devices Revolutionized Manufacturing

    5 Current Trends in Medical Device Security

    How Advanced Sensors Improve Design & Functionality of Respiratory Care Equipment
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Providence Enterprise USA Inc.

    NDH Medical Inc.

    Cirtec Medical

    Forefront Medical Technology

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA to Modernize Mammography Services and Improve Their Quality

    Proposed rule would require breast density reporting, enhance the FDA’s ability to enforce mammography facilities’ compliance with standards.

    FDA to Modernize Mammography Services and Improve Their Quality
    For the first time in more than 20 years of regulating mammography facilities, the agency is proposing amendments to key regulations that would help improve the quality of mammography services for millions of Americans.
    U.S. Food and Drug Administration03.27.19
    Today, the U.S. Food and Drug Administration announced important new steps to modernize breast cancer screening and help empower patients with more information when they are considering important decisions regarding their breast healthcare.
     
    For the first time in more than 20 years of regulating mammography facilities, the agency is proposing amendments to key regulations that would help improve the quality of mammography services for millions of Americans. Today’s actions would expand the information mammography facilities must provide to patients and healthcare professionals, allowing for more informed medical decision-making. It would also modernize mammography quality standards and better position the FDA to enforce regulations that apply to the safety and quality of mammography services.
     
    “Breast cancer is one of the most worrisome health concerns facing women. The FDA plays a unique and meaningful role in the delivery of quality mammography to help patients get accurate screening to identify breast health problems early, when they can be effectively addressed,” said FDA Commissioner Scott Gottlieb, M.D. “As part of our overall commitment to protecting the health of women, we’re proposing new policies to modernize our oversight of mammography services, by capitalizing on a number of important advances in mammography, like the increased use of 3-D digital screening tools and the need for more uniform breast density reporting. We’re committed to making sure patients have access to high-quality mammography. Today’s proposed rule would help to ensure patients continue to benefit from advances in new tools and robust oversight of this field.”
     
    According to the National Cancer Institute (NCI), approximately 12.4 percent of women will be diagnosed with breast cancer at some point during their lifetime. NCI estimates that, in 2018, more than 260,000 women were diagnosed with breast cancer and more than 40,920 women died of the disease. Aside from skin cancer, breast cancer is the most common cancer among women and the second leading cause of death. Additionally, mammography can be an important tool in detecting male breast cancers. According to the NCI, breast cancer may occur in men at any age but usually occurs in men between 60-70 years of age.
     
    The FDA’s proposal would amend regulations issued under the Mammography Quality Standards Act of 1992 (MQSA), which Congress passed to ensure quality mammography for early breast cancer detection. The MQSA authorizes FDA oversight over mammography facilities, including their accreditation, certification, annual inspections and enforcement of standards to help ensure mammography facilities provide quality care.
     
    Among the proposed amendments to improve communication and medical decision making is the addition of breast density information to the mammography lay summary letter provided to patients and to the medical report provided to their referring healthcare professionals. Mammograms of dense breasts—breasts with a higher proportion of fibroglandular tissue compared to fatty tissue—can be difficult to interpret because the dense tissue can obscure signs of breast cancer and lower the sensitivity of the image. Dense breasts have also been identified as a risk factor for developing breast cancer. The FDA is proposing specific language that would explain how breast density can influence the accuracy of mammography and would recommend patients with dense breasts talk to their healthcare provider about high breast density and how it relates to breast cancer risk and their individual situation.
     
    The proposed amendments also seek to enhance information provided to healthcare professionals by proposing to codify three additional categories for the assessments of mammograms, including adding an important category titled “known biopsy proven malignancy,” which would help identify for healthcare professionals those cases where cancer being mammographically evaluated for therapy are already known and identified. In addition, under the proposed regulations, both healthcare professionals and patients would receive in their reports and lay summary letters more detailed identifying information about the mammography facility to aid in post-exam communications.
     
    “The FDA is committed to advancing efforts that improve the health of women. We believe the proposed rule would help empower patients and healthcare professionals by proposing improvements to the information facilities communicate to them, helping to facilitate the sometimes difficult conversations about potential risks for breast cancer,” said FDA Principal Deputy Commissioner Amy Abernethy, M.D., Ph.D. “Given that more than half of women over the age of 40 in the U.S. have dense breasts, helping to ensure patient access to information about the impact that breast density and other factors can have on the risk for developing breast cancer is an important part of a comprehensive breast health strategy. Today’s proposed amendments are part of the agency’s broader commitment to supporting new innovations and methods to prevent, detect and treat cancer. We are dedicated to working across the agency and with stakeholders to provide patients with tools and information to fight breast cancer effectively.”
     
    The proposed amendments would also modernize mammography quality standards and better position FDA to enforce the MQSA regulations and take action when violations are found. Some of these proposed changes include:
     
    Expressly stating that the FDA can directly notify patients and their healthcare professionals, should facilities be unwilling or unable to do so, that mammography at a facility did not meet quality standards and that reevaluation or repeat of the mammogram at another certified facility may be needed;
    Requiring that only digital accessory components specifically FDA approved or cleared for mammography be used, or that facilities use components that otherwise meet the requirements under the rule;
    Strengthening record-keeping requirements to minimize information loss and improve access to and transfer of patient mammography records.
     
    “Once finalized, these proposed amendments will enhance our oversight of mammography facilities, including in the key area of enforcement and patient communication,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health. “While the majority of certified mammography facilities are dedicated to providing high levels of patient care, today’s proposed regulations would enhance the FDA’s ability to communicate directly, if needed, with patients and their healthcare professionals in cases where facilities did not meet our quality standards and are not adequately communicating with patients about their facillities’ deficiencies. This is intended to help ensure important information that could affect decisions about patient care—such as the potential need for further evaluation or a repeat of a mammogram—is communicated as quickly as possible.”
     
    The proposed rule is available online at www.regulations.gov for public comment for 90 days from publication.
    Related Searches
    • breast cancer
    • first
    • it
    • congress
    Related Knowledge Center
    • Diagnostics
      Loading, Please Wait..

      Trending
      • Medinbox And Abbott Partner To Increase Efficiency In Electrophysiology Labs
      • Masimo Reveals Freedom Health-Tracking Smartwatch
      • FDA OKs FemDx Medsystems' FalloView Device
      • Getinge’s Cardiosave Faces CE-Certificate Suspension From TÜV SÜD
      • A New Approach To Post-Market Surveillance
      Breaking News
      • Tracey Technologies Upgrades iTrace Software
      • Foster Corporation Rebrands its Distribution Business
      • Greenleaf Health Recruits Two Former FDA Officials
      • TOTAL Toric Contact Lenses for Astigmatism Debuts in Canada
      • FDA Approves Abbott's Epic Max Tissue Valve for Aortic Valve Disease
      View Breaking News >
      CURRENT ISSUE

      March 2023

      • Sensing Technology Drives the Future of Medical Care
      • New and Developing Diabetes Technologies Offer 'Sweet Relief'
      • Discussing Matters of Substance in Medtech Materials
      • Medical Device Testers Are Caught Up in a Whirlwind
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Hyaluronic Acid Ingredient Linked to Antioxidant Benefits In Vitro
      Anita Johansen Appointed New CEO of Probi
      Kemin Human Nutrition & Health Acquires Oral Health Ingredient
      Coatings World

      Latest Breaking News From Coatings World

      PPG Names Rodolfo Ramirez GM, Packaging Coatings
      Sherwin-Williams Unveils High Performance Interior Marine Decking Systems
      AkzoNobel Appoints Ricardo Rosso as Pontiac Site Manager
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Tracey Technologies Upgrades iTrace Software
      Foster Corporation Rebrands its Distribution Business
      Greenleaf Health Recruits Two Former FDA Officials
      Contract Pharma

      Latest Breaking News From Contract Pharma

      ABL Names Stephanie Colloud GM and COO in Europe
      Catawba Research Names Andrew Silverman COO
      Evonik Begins Construction of $220M U.S. Facility for Pharmaceutical Lipids
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      MAC Revamps 'Back To MAC' Recycling Program
      Coty Names New Chief Commercial Officer for Prestige Division
      GK Launches Vegan Hair Styling Range
      Happi

      Latest Breaking News From Happi

      Actor, Model Evan Mock Introduces Vegan Genderless Skin Care Brand Good Weird to Beauty Market
      MAC Cosmetics Brings Back Improved ‘Back-To-MAC’ Takeback Program
      Sederma Introduces Active Ingredient to Address Pigment Disorders
      Ink World

      Latest Breaking News From Ink World

      INX International Makes Investment in Gooten
      Videojet Launches 1580 C Soft-Pigmented Contrast Printer
      Epson to Showcase Textile, Signage and Aqueous Printers at ISA 2023
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Loftware secures significant growth equity investment
      Avery Dennison’s atma.io adds new ChatGPT and AI features
      Reproflex3 wins regional business award
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Drylock Technologies Plants First trees in Drylock Forest
      A.Celli Group to Hold Open House
      Toray Awarded for Nanodesign Technology
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Report: No Complications With OssDsign Catalyst Graft
      FDA OKs Bioretec's RemeOs Bioresorbable Metal Trauma Screw
      First Clinical Use of Stryker’s Tornier Pyrocarbon Humeral Head
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      Universal Display Sponsors, Presents at ICDT 2023
      Miron Washington Joins Impinj Board of Directors
      All-Time High for Global 300MM Semiconductor Capacity in 2026: SEMI

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login